Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP26A1 | O43174 | 6/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | RARA | P10276 | 2/20 | 0.34 |
| ▸ | RARB | P10826 | 2/20 | 0.34 |
| ▸ | RARG | P13631 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | PGR | P06401 | 1/20 | 0.34 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.34 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.34 |
| ▸ | BLVRB | P30043 | 1/20 | 0.34 |
| ▸ | CYP26B1 | Q9NR63 | 5/20 | 0.34 |
| ▸ | RXRA | P19793 | 2/20 | 0.33 |
| ▸ | RXRB | P28702 | 2/20 | 0.33 |
| ▸ | RXRG | P48443 | 1/20 | 0.31 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25126829 | 0.90 | CYP26A1 (0.32) | CYP26A1MEN1CYP3A4RARARARB | |
| SCHEMBL25128669 | 0.90 | JAK2 (0.31) | CYP26A1MEN1CYP3A4RARARARB | |
| SCHEMBL25126778 | 0.88 | RXRA (0.32) | CYP26A1CYP26B1RXRARXRBRXRG | |
| SCHEMBL25128111 | 0.87 | KIF11 (0.30) | — | |
| SCHEMBL23589607 | 0.84 | AKR1C3 (0.36) | MEN1KMT2AALDH1A1MAPK1 | |
| SCHEMBL25127093 | 0.81 | — | — | |
| SCHEMBL25127074 | 0.79 | AKR1C3 (0.30) | — | |
| SCHEMBL21846305 | 0.78 | RXRA (0.37) | CYP26A1CYP26B1RXRARXRBRXRG | |
| SCHEMBL25128050 | 0.76 | RXRA (0.38) | CYP26A1RARARARBRARGCYP26B1 | |
| SCHEMBL23116372 | 0.76 | CYP26A1 (0.47) | CYP26A1MEN1CYP3A4RARARARB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230096132-A1 | CYCLOALKANE-FUSED POLYCYCLIC AROMATIC COMPOUND | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2023-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230096132-A1 | CYCLOALKANE-FUSED POLYCYCLIC AROMATIC COMPOUND | LAGE3, ELOC, ELOB | CYP26A1 3367/4885MEN1 3848/4885CYP3A4 2615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.